Actemra solution for subcutaneous injection
Actemra 170613 1 Consumer Medicine Information . Actemra ® solution for subcutaneous injection . Tocilizumab . 162 mg/0.9 …
Download Actemra solution for subcutaneous injection
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Hepatitis A: Questions and answers
immunize.orgÕ â>Ì ÊVÌ Ê > Ì ÊÊUÊÊ-> ÌÊ*>Õ ]Ê ià Ì>ÊÊUÊÊÈx£®ÊÈ{Ç ää ÊÊUÊÊÜÜÜ°Û>VV i v À >Ì ° À}ÊÊUÊÊÜÜÜ° Õ âi° À}
251 Acute Liver Failure in Critical Care - …
www.frca.co.ukSign up to receive ATOTW weekly - email worldanaesthesia@mac.com ! ATOTW 251 – Management of Acute Liver Failure in Critical Care 20/02/2012 Page 3 of 9
270 Anaesthesia and Liver disease Part 1 - FRCA
www.frca.co.ukSign up to receive ATOTW weekly - email worldanaesthesia@mac.com ! ATOTW 270 – Anaesthesia and Liver Disease – Part 1 03/09/2012 Page 2 of 7
9395126 Liv. Env. Ja04 - Regents Examinations
www.nysedregents.orgThe University of the State of New York REGENTS HIGH SCHOOL EXAMINATION LIVING ENVIRONMENT Thursday, January 29, 2004 — 9:15 …
Hepatitis B and the health care worker - WHO
www.who.intHow often should I test health care workers after they've received the hepatitis B vaccine series to make sure they're protected? Postvaccination testing should be done 1–2
Tuberculosis: General Information
www.cdc.govNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Tuberculosis Elimination. CS227840_A. TB Elimination. Tuberculosis…